跳至主要内容
临床试验/ISRCTN05823740
ISRCTN05823740已完成不适用

Coenzyme Q10 therapy in lithotripsy in patients with renal lithiasis: a prospective randomised double-blind trial

Association of Urology Research and Development (Asociacion de Urologia y Desarrollo de la Investigacion) (Spain)0 个研究点目标入组 112 人开始时间: 2010年3月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
112

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Adult patients aged 25 to 65 years (either sex) with urinary tract lithiasis
  • 2. Candidates to applying lithotripsy
  • 3. Lithiasis located in the renal pelvis and/or calyx

排除标准

  • 1. Patients undergoing lithotripsy at the time of initiating the study
  • 2. Patients with previously diagnosed renal lithotripsy
  • 3. Patients treated with calcium channel blockers
  • 4. Complications of lithotripsy that determine the need for further intervention in the study period
  • 5. Taking antiplatelet 3 days before extracorporeal shock-wave lithotripsy (ESWL) session
  • 6. Controlled clotting disorders
  • 7. Complete distal obstruction to the calculation to be treated
  • 8. Unrecovery kidney
  • 9. Allergy to the components of medications
  • 10. Inability to understand or psychosocial misadjustment
  • 11. Refusal to sign informed consent

研究者

发起方
Association of Urology Research and Development (Asociacion de Urologia y Desarrollo de la Investigacion) (Spain)

相似试验